SQNM, LIFE and ILMN Rated by Street-Wire as Biotech Companies See …SmallCap NetworkOn Monday, Life Technologies announced the receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing …
New Zealand Coroner: Woman's Addiction to Coca-Cola Binging Caused Her … – International Business Times
 International Business Times |
New Zealand Coroner: Woman’s Addiction to Coca-Cola Binging Caused Her …
International Business Times A coroner in New Zealand concluded that a 31-year-old woman from the southern town of Glengarry died from heart failure, largely because she drank up to 2.6 gallons (10 liters) of Coca-Cola per day. That’s equivalent to about 2.2 pounds of raw sugar … Coke consumption major factor in death, Coroner rules3News NZ |
PRN Physician Recommended Nutriceuticals Announces the Launch of an … – Canada NewsWire (press release)
PRN Physician Recommended Nutriceuticals Announces the Launch of an …Canada NewsWire (press release)He is an expert in stem cell transplantation, tissue engineering, corneal procedures, LASIK and other refractive surgery techniques, and has also inve…
Weekend cyclosporine A therapy comparable to daily treatment for psoriasis – Healio
Weekend cyclosporine A therapy comparable to daily treatment for psoriasisHealioA 2-day weekend regimen and a continuous regimen of cyclosporine A for 20 weeks showed comparable results as treatment for plaque psoriasis, according to data from a recent…
Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System … – PR Newswire (press release)
|
Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System …
PR Newswire (press release) 12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable polymer drug-eluting … |
Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System … – MarketWatch (press release)
Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System …MarketWatch (press release)It is the only platform to feature a customized Platinum Chromium (PtCr) stent architecture, the market-leading Everolimus drug coating and fluorinated c…
Honors & Other Things – UPENN Almanac
Honors & Other ThingsUPENN AlmanacDr. June received the prize along with Dr. Bruce R. Blazar of the University of Minnesota for their significant advances in the field of bone marrow transplantation (BMT) and adoptive immunotherapy. The Ernest Beut…
Stem Cells Industry: The Battle Within – Forbes India
Forbes IndiaStem Cells Industry: The Battle WithinForbes IndiaFor seven years, the startup, promoted by the Manipal Group and led by chief executive BN Manohar, has been at the bench studying stem cells in its labs in India and Malaysia. With a series …
Inotuzumab/rituximab combination shows promise in NHL – Healio
 Healio |
Inotuzumab/rituximab combination shows promise in NHL
Healio The phase 1/2 study aimed to determine the maximum tolerated dose of inotuzumab ozogamicin plus rituximab (Rituxan, Genentech/Idec Pharmaceuticals) in a cohort of patients with relapsed/refractory CD20+/CD22+ B-cell non-Hodgkin’s lymphoma. |
Rally champ signs up as organ donor – ITV News
 ITV News |
Rally champ signs up as organ donor
ITV News “After a quick registration online, I’m now happy to say that I’m signed up as an organ donor. “I would urge everyone to consider signing up, as it really can change somebody’s life.” You can find more information on how to join, on the dedicated … |